Trends in the Prevalence and Diagnosis of Hypertensive Heart Diseases

Ademuyiwa Adewole Isaac; Ademuyiwa Adeyinka Eunice; Professor Olaniyan Matthew

doi:10.56201/ijhpr.vol.11.no4.2026.pg104.114

📄 Download Paper

Trends in the Prevalence and Diagnosis of Hypertensive Heart Diseases

Ademuyiwa Adewole Isaac, Ademuyiwa Adeyinka Eunice, ., Professor Olaniyan Matthew

Abstract

Hypertensive heart diseases pose a global health challenge, contributing to morbidity and mortality. Understanding the disease's aspects is crucial to reduce its burden. Laboratory diagnostics have advanced in diagnosing and managing HHD. Integration of emerging biomarkers, imaging techniques, genetics, Omics technologies, and AI analytics can transform clinical practice and improve outcomes. Challenges in laboratory diagnosis include lack of specific biomarkers, variability in biomarker levels, overlapping clinical presentations, limited accessibility and high cost of imaging, genetic complexity, and ethical considerations. Addressing these challenges requires research, standardization, accessibility, collaboration, validation, and patient empowerment. The prevalence of HHD is increasing globally by 137.91% from 7.82million in 1990, due to urbanization, unhealthy lifestyles, aging populations, and socioeconomic disparities. Raising awareness, improving healthcare access, and implementing preventive measures are essential. A comprehensive approach integrating public health initiatives, healthcare system strengthening, and individual empowerment is necessary. In Nigeria, HHD prevalence is rising due to urbanization, lifestyle changes, socioeconomic disparities, an aging population, and limited healthcare infrastructure. Addressing these trends requires prevention, early detection, and effective hypertension management. Strengthening healthcare systems, promoting health education, and implementing targeted interventions are crucial in reducing the burden of HHD in Nigeria. Research and knowledge gaps exist in the field of trends in the prevalence and laboratory diagnosis of hypertensive heart diseases . These gaps hinder our understanding of the disease, limit effective diagnostic and management strategies, and impede the development of evidence-based interventions. Key research gaps include the lack of standardized diagnostic criteria, the need for longitudinal studies to track disease trends, biomarker discovery and validation, integration of omics technologies, development of accessible diagnostic tools, addressing ethical and legal considerations, and understanding health disparities. Addressing these gaps will contribute to improved strategies for early detection, management, and prevention of HHD.

References

Augustine N Odili, Babangida S Chori, Benjamin Danladi, Peter C Nwakile, Innocent C Okoye, Umar Abdullahi, Maxwell N Nwegbu, Kefas Zawaya, Ime Essien, Kabiru Sada, John O Ogedengbe , Akinyemi Aje 9, Godsent C Isiguzo, (2020) Prevalence, Awareness, Treatment and Control of Hypertension in Nigeria: Data from a Nationwide Survey 2017. Glob Heart. 2020 Jul 10; 15(1):47. doi: 10.5334/gh.848. Davies Adeloye,, Eyitayo O. Owolabi, Dike B. Ojji, Asa Auta , Mary T. Dewan, Timothy O. Olanrewaju, Okechukwu S. Ogah (2021) Prevalence, awareness, treatment, and control of hypertension in Nigeria in 1995 and 2020: A systematic analysis of current evidence. Clinical Journal of Hypertension: Volume23, Issue 5: 963-977 Gary Tackling, Mahesh B. Borhade (2022) Hypertensive Heart Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; PMID: 30969622 Bookshelf ID: NBK539800 Robert M Carey, Jackson T Wright Jr Sandra J Taler, Paul K Whelton (2021) Guideline-Driven Management of Hypertension: An Evidence-Based Update Circ Res 2;128(7):827-846. Flávio D Fuchs, Paul K Whelton (2020) High Blood Pressure and Cardiovascular Disease Hypertension; 75(2):285-292. Westaby J D, C Miles I Chis Ster 3, S T E Cooper 2, T F Antonios 2, D Meijles, E R Behr , M N Sheppard (2022) Characterization of hypertensive heart disease: pathological insights from a sudden cardiac death cohort to inform clinical practice J Hum Hypertens. ;36(3):246-253. Chike C Nwabuo, Ramachandran S Vasan (2020) Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy. Curr Hypertens Rep.; 22(2):11. doi: 10.1007/s11906-020-1017-9. 8.Weronika Frąk, Armanda Wojtasińska 1, Wiktoria Lisińska, Ewelina Młynarska, Beata Franczyk, Jacek Rysz (2022)Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease. Biomedicines; 10(8):1938. doi: 10.3390/biomedicines10081938. Westaby, J.D., Miles, C., Chis Ster, I, S T E Cooper, T F Antonios, D Meijles , E R Behr, M N Sheppard 2. (2022). Characterization of hypertensive heart disease: pathological insights from a sudden cardiac death cohort to inform clinical practice. J Hum Hypertens 36, 246–253 https://doi.org/10.1038/s41371-021-00507-6 Nadar, S.K., Lip, G.Y.H. (2021). The heart in hypertension. J Hum Hypertens 35, 383–386 https://doi.org/10.1038/s41371-020-00427-x cohort to inform clinical practice Suzanne Oparil, Maria Czarina Acelajado, George L. Bakris, Dan R. Berlowitz, Renata Cífková, Anna F. Dominiczak, Guido Grassi, Jens Jordan, Neil R. Poulter, Anthony Rodgers & Paul K. Whelton (2018) Hypertension. Nat Rev Dis Primers 4, 18014. https://doi.org/10.1038/nrdp.2018.14 Diamond, J., Phillips, R. (2005). Hypertensive Heart Disease. Hypertens Res 28, 191–202 https://doi.org/10.1291/hypres.28.191 Nadar, S.K., Lip, G.Y.H. (2021). The heart in hypertension. J Hum Hypertens 35, 383–386 https://doi.org/10.1038/s41371-020-00427

Trends in the Prevalence and Diagnosis of Hypertensive Heart Diseases

Abstract

References

More Articles from INTERNATIONAL JOURNAL OF HEALTH AND PHARMACEUTICAL RESEARCH